Document is current

Any future updates will be listed below

Investigating the cost implications of including all respiratory medicines in PCRS schemes

Crossref DOI link: https://doi.org/10.1007/s11845-017-1734-5

Published Online: 2018-02-01

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark